Trials / Completed
CompletedNCT02783651
An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
An Observational Study of Patients With Philadelphia Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 212 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A retrospective chart review study of Philadelphia chromosome-negative R/R ALL patients in the US.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Other | No intervention other than routine medical care |
Timeline
- Start date
- 2016-06-30
- Primary completion
- 2020-03-31
- Completion
- 2020-03-31
- First posted
- 2016-05-26
- Last updated
- 2020-04-27
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02783651. Inclusion in this directory is not an endorsement.